| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 70 |
| 1 | ACETAMINOPHEN 500MG | 57 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 57 |
| 3 | PAIN RELIEVER | 57 |
| 4 | METFORMIN | 45 |
| 5 | METFORMIN ER 500 MG | 45 |
| 6 | METFORMIN ER 750 MG | 45 |
| 7 | GABAPENTIN | 22 |
| 8 | EMPAGLIFLOZIN | 19 |
| 9 | IBUPFROFEN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROPYLHEXEDRINE | 4 | 0.0690 |
| 1 | DARUNAVIR 600 MG | 10 | 0.0016 |
| 2 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 3 | ELAFIBRANOR | 1 | 0.0011 |
| 4 | LATANOPROSTENE BUNOD | 1 | 0.0009 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 7 | 0.0008 |
| 6 | NATEGLINIDE | 1 | 0.0007 |
| 7 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 0.0007 |
| 8 | RITONAVIR 100 MG | 10 | 0.0007 |
| 9 | FLUNISOLIDE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 80 |
| 1 | Benzodiazepine [EPC] | 29 |
| 2 | Opioid Agonist [EPC] | 21 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 19 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| 5 | Loop Diuretic [EPC] | 16 |
| 6 | Atypical Antipsychotic [EPC] | 15 |
| 7 | beta-Adrenergic Blocker [EPC] | 14 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 13 |
| 9 | Expectorant [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 1 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Sigma-1 Agonist [EPC] | 4 | 0.0005 |
| 3 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Protease Inhibitor [EPC] | 10 | 0.0002 |
| 6 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 19 | 0.0002 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 10 | 0.0002 |
| 9 | Dietary Cholesterol Absorption Inhibitor [EPC] | 13 | 0.0001 |